(PCAR) PACCAR - Overview
Stock: Trucks, Parts, Leasing, Financing, Winches
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.59% |
| Yield on Cost 5y | 5.68% |
| Yield CAGR 5y | -1.07% |
| Payout Consistency | 88.9% |
| Payout Ratio | 53.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.7% |
| Relative Tail Risk | -16.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | 8.21 |
| Character TTM | |
|---|---|
| Beta | 0.852 |
| Beta Downside | 0.762 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.75% |
| CAGR/Max DD | 0.91 |
Description: PCAR PACCAR January 27, 2026
PACCAR Inc. (NASDAQ:PCAR) designs, manufactures, and distributes light-, medium-, and heavy-duty commercial trucks across North America, Europe, South America, and Australia. The business is organized into three segments: Truck (Kenworth, Peterbilt, DAF), Parts (aftermarket components), and Financial Services (PacLease leasing and financing for dealers, fleets, and owners). The company also markets industrial winches under the Braden, Carco, and Gearmatic brands.
In FY 2023 PACCAR reported revenue of roughly **$25.2 billion**, with the Truck segment contributing about 78 % of sales and delivering **~106 k trucks** worldwide-a 5 % increase year-over-year driven by strong demand in North America and Europe. The Parts segment grew **6 %** on a comparable-basis, reflecting higher aftermarket utilization as fleets replace older equipment. Financial Services generated **$3.0 billion** in revenue (≈12 % of total) and benefited from a **3.2 %** net interest margin despite a rising U.S. Federal Funds rate, which is gradually tightening leasing terms. Key macro drivers include a **3 % YoY rise in U.S. freight tonnage** (U.S. DOT) and a **moderate slowdown in global truck-sales cycles** as manufacturers adjust to tighter credit conditions.
For a deeper quantitative assessment of PCAR’s valuation relative to peers, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.38b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 19.45% < 20% (prev 63.08%; Δ -43.64% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.42b > Net Income 2.38b |
| Net Debt (-9.25b) to EBITDA (3.91b): -2.37 < 3 |
| Current Ratio: 1.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (526.8m) vs 12m ago 0.02% < -2% |
| Gross Margin: 16.23% > 18% (prev 0.20%; Δ 1603 % > 0.5%) |
| Asset Turnover: 64.83% > 50% (prev 77.53%; Δ -12.70% > 0%) |
| Interest Coverage Ratio: 7.94 > 6 (EBITDA TTM 3.91b / Interest Expense TTM 387.8m) |
Altman Z'' 3.50
| A: 0.12 (Total Current Assets 13.42b - Total Current Liabilities 7.89b) / Total Assets 44.34b |
| B: 0.43 (Retained Earnings 19.05b / Total Assets 44.34b) |
| C: 0.07 (EBIT TTM 3.08b / Avg Total Assets 43.88b) |
| D: 0.77 (Book Value of Equity 19.26b / Total Liabilities 25.07b) |
| Altman-Z'' Score: 3.50 = A |
Beneish M 0.39
| DSRI: 0.11 (Receivables 1.98b/21.25b, Revenue 28.44b/33.66b) |
| GMI: 1.23 (GM 16.23% / 19.93%) |
| AQI: 7.92 (AQ_t 0.60 / AQ_t-1 0.08) |
| SGI: 0.84 (Revenue 28.44b / 33.66b) |
| TATA: -0.05 (NI 2.38b - CFO 4.42b) / TA 44.34b) |
| Beneish M-Score: 0.39 (Cap -4..+1) = D |
What is the price of PCAR shares?
Over the past week, the price has changed by +3.61%, over one month by +8.77%, over three months by +31.67% and over the past year by +21.36%.
Is PCAR a buy, sell or hold?
- StrongBuy: 5
- Buy: 2
- Hold: 12
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the PCAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 122.2 | -4.1% |
| Analysts Target Price | 122.2 | -4.1% |
| ValueRay Target Price | 155.7 | 22.2% |
PCAR Fundamental Data Overview February 07, 2026
P/E Forward = 22.8833
P/S = 2.3536
P/B = 3.5123
P/EG = 1.3771
Revenue TTM = 28.44b USD
EBIT TTM = 3.08b USD
EBITDA TTM = 3.91b USD
Long Term Debt = 10.77b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.08b USD (from shortTermDebt, two quarters ago)
Debt = 15.85b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -9.25b USD (from netDebt column, last quarter)
Enterprise Value = 73.54b USD (66.95b + Debt 15.85b - CCE 9.25b)
Interest Coverage Ratio = 7.94 (Ebit TTM 3.08b / Interest Expense TTM 387.8m)
EV/FCF = 24.28x (Enterprise Value 73.54b / FCF TTM 3.03b)
FCF Yield = 4.12% (FCF TTM 3.03b / Enterprise Value 73.54b)
FCF Margin = 10.65% (FCF TTM 3.03b / Revenue TTM 28.44b)
Net Margin = 8.35% (Net Income TTM 2.38b / Revenue TTM 28.44b)
Gross Margin = 16.23% ((Revenue TTM 28.44b - Cost of Revenue TTM 23.83b) / Revenue TTM)
Gross Margin QoQ = 13.83% (prev 16.18%)
Tobins Q-Ratio = 1.66 (Enterprise Value 73.54b / Total Assets 44.34b)
Interest Expense / Debt = 0.10% (Interest Expense 15.2m / Debt 15.85b)
Taxrate = 21.00% (148.0m / 704.9m)
NOPAT = 2.43b (EBIT 3.08b * (1 - 21.00%))
Current Ratio = 1.70 (Total Current Assets 13.42b / Total Current Liabilities 7.89b)
Debt / Equity = 0.82 (Debt 15.85b / totalStockholderEquity, last quarter 19.26b)
Debt / EBITDA = -2.37 (Net Debt -9.25b / EBITDA 3.91b)
Debt / FCF = -3.05 (Net Debt -9.25b / FCF TTM 3.03b)
Total Stockholder Equity = 18.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.41% (Net Income 2.38b / Total Assets 44.34b)
RoE = 12.57% (Net Income TTM 2.38b / Total Stockholder Equity 18.90b)
RoCE = 10.38% (EBIT 3.08b / Capital Employed (Equity 18.90b + L.T.Debt 10.77b))
RoIC = 7.03% (NOPAT 2.43b / Invested Capital 34.59b)
WACC = 7.33% (E(66.95b)/V(82.80b) * Re(9.05%) + D(15.85b)/V(82.80b) * Rd(0.10%) * (1-Tc(0.21)))
Discount Rate = 9.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.11%
[DCF Debug] Terminal Value 82.80% ; FCFF base≈2.98b ; Y1≈3.48b ; Y5≈5.24b
Fair Price DCF = 214.0 (EV 103.19b - Net Debt -9.25b = Equity 112.44b / Shares 525.4m; r=7.33% [WACC]; 5y FCF grow 18.05% → 2.90% )
EPS Correlation: -29.68 | EPS CAGR: -2.15% | SUE: -0.07 | # QB: 0
Revenue Correlation: -6.86 | Revenue CAGR: 1.41% | SUE: 4.0 | # QB: 9
EPS next Quarter (2026-03-31): EPS=1.17 | Chg30d=-0.030 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-12-31): EPS=5.65 | Chg30d=+0.135 | Revisions Net=+3 | Growth EPS=+25.3% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=6.73 | Chg30d=-0.401 | Revisions Net=-1 | Growth EPS=+19.2% | Growth Revenue=+10.3%